Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emodepside Phase 1 SAD in Healthy Volunteers
NCT02661178Phase 1Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Dec 2015
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in onchocerciasis comparing Emodepside with Placebo (2 arms). Primary endpoints: Safety and Tolerability as Measured by Adverse Events, Safety and Tolerability as Measured by Physical and Neurological Examination Findings and 4 more. Started Dec 2015; status: completed.
02
Drugs
emodepside
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT02661178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02661178.